Also listed on Pear Therapeutics US Inc, an earlier holder on the record. The recorded assignments below show how it moved.
Term ends Mar 16, 2039 · Low confidence
20-year base term ends Oct 10, 2038
Oct 10, 2018
Mar 16, 2039
May 23, 2023
This patent's term runs 157 days past its 20-year base term on prosecution delay. A terminal disclaimer is resolved from the filed document, and it ends no earlier than this term, so it shortens nothing. 1 of 3 maintenance fees is paid so far. Confidence: Low. from the record
How we calculated this date
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Oct 10, 2018, when application 16/156,373, the earliest non-provisional in its chain, was filed (this one was filed Mar 15, 2021); a parent in its chain could not be resolved (the next row) | Oct 10, 2038 | High confidence |
| Continuity chain | A parent in the chain could not be resolved | dated from this application's own claim | Medium confidence |
| Patent term adjustment | +157 days, USPTO patent term adjustment record | Mar 16, 2039 | High confidence |
| Terminal disclaimer cap | Disclaimer resolved from the filed document (refs US 10,986,071) | resolves to Mar 16, 2039, no earlier than this term, so no change | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 1 of 3 maintenance fees paid | In force | High confidence |
| Further caveats on record | The record names parents not resolved: 16156373 | Low confidence overall | Low confidence |
| Computed term end | The steps above, in order | Mar 16, 2039 | Low confidence |
This family
| US 10,986,071 | In force Jul 2039 | Jul 2039 |
| US 11,658,946 | this patent Mar 2039 | Mar 2039 |
| US 11,916,888 | In force no later than Oct 2038 | no later than Oct 2038 |
| US 12,580,899 | In force no later than May 2039 | no later than May 2039 |
| Application 19/451,157 | Pending not computed | not computed |
Assignments
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Mar 15, 2021 Reel 55595, frame 914 | McFarland, Ian; Pallone, Davina; Ma, Jason F.; Barbosa, Daniel; Trinh, Phu | Pear Therapeutics, Inc. | Assignment of Assignor's Interest |
| Apr 11, 2022 Reel 59561, frame 589 | Pear Therapeutics, Inc. | Pear Therapeutics (US), Inc. | Change of Name |
| Dec 15, 2022 Reel 62137, frame 135 | Pear Therapeutics, Inc. | Perceptive Credit Holdings III, LP | Patent Security Agreement |
| Jul 7, 2023 Reel 64228, frame 813 | Pear Therapeutics (US), Inc. | Click Therapeutics, Inc. | Assignment of Assignor's Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
What's changing
A terminal disclaimer resolved from the filed document, referencing US 10,986,071, ends no earlier than this term, so it caps nothing.